• Takeda Completes Acquisition of ARIAD Pharmaceuticals americanpharmaceuticalreview
    February 20, 2017
    Takeda Pharmaceutical Company has announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 per share in cash.
  • Takeda to Acquire ARIAD Pharmaceuticals americanpharmaceuticalreview
    January 11, 2017
    Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals have entered into a definitive agreement under which Takeda will acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, or an enterprise value of approximately $5.2 bill
PharmaSources Customer Service